X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmaceutical-technology.com/news/otsuka-lundbeck-schizophrenia/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213037
https://www.biospace.com/article/fda-greenlights-first-bi-monthly-injectable-for-schizophrenia-bipolar-1-disorder-/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-26-2023-60580.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2023-46659.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216351
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215595
https://www.fiercepharma.com/pharma/fda-accepts-otsuka-lundbeck-filing-long-acting-schizophrenia-drug-teeing-april-decision-date
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-27-2022-1659339221.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203025
https://www.statnews.com/2021/10/07/backed-with-500-million-a-startup-aims-to-rethink-psychiatric-drug-development/
https://www.indiainfoline.com/article/news-sector-pharma-healthcare/unichem-lab-receives-usfda-approval-for-aripiprazole-tablets-stock-soars-3-121070100415_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203025
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-9-2020-1607497312.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-1-2020-1593586904.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212870
http://www.pmlive.com/pharma_news/lundbecks_key_products_shine_in_q2_but_problems_remain_1297435
https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-aripiprazole-1mg-ml-oral-solution-el-19-a-20
https://www.fiercepharma.com/marketing/biohaven-touts-oral-cgrp-data-moves-closer-to-regulatory-finish-line-and-maybe-m-a
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210479
https://www.usatoday.com/story/opinion/2019/01/12/why-fda-doesnt-always-catch-tainted-medicines/2538786002/
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-for-antipsychotic-drug/67437325
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208260
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208438
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=910201811531
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206240
https://www.fiercepharma.com/manufacturing/fosun-pharma-massively-fakes-api-production-data-and-bribes-regulators-whistle-blower
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090165
https://www.statnews.com/2018/08/30/abilify-digital-medicaid-mental-illness/
https://www.biospace.com/article/woman-sues-abilify-marketers-over-hefty-gambling-losses/
http://phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-newsArticle&ID=2356744
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207240
https://timesofindia.indiatimes.com/business/india-business/japanese-firms-patent-on-anti-psychotic-drug-rejected/articleshow/63296246.cms
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-21-2018-1519194777.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-14-2018-1518587433.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205363
http://www.pmlive.com/pharma_news/first_digital_medicine_approved_in_the_us_1211409
http://www.businesswire.com/news/home/20170728005437/en/ABILIFY-MAINTENA%C2%AE-aripiprazole-Extended-Release-Injectable-Suspension-Approved/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J
http://www.pmlive.com/pharma_news/otsuka_refiles_digital_medicine_for_mental_illness_1194209
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202683
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-10-2017-1494391927.pdf
https://www.pharmacompass.com/pdf/news/abilify-aripiprazole-otsuka-pharmaceutical-v-zydus-cadila-healthcare-ltd-1494843247.pdf
Market Place
Share 
